-
Mashup Score: 13SCAI Expert Consensus Statement on Alternative Access for Transcatheter Aortic Valve Replacement - 3 day(s) ago
Transcatheter aortic valve replacement (TAVR) has become a widely accepted procedure for treating patients with symptomatic aortic stenosis. While transfemoral access remains the primary route due to its lower complication rates and favorable outcomes, a subset of patients have anatomical or clinical factors precluding this approach. For these patients, alternative access routes such as transaxillary, transcarotid, and transcaval provide viable options. This expert consensus statement aims to provide a comprehensive review of case selection, technical considerations, and outcomes associated with these alternative access routes in TAVR.
Source: www.jscai.orgCategories: General Medicine NewsTweet
-
Mashup Score: 23The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma - 7 day(s) ago
For decades, the management of coronary artery disease has focused on epicardial obstruction and ischaemia, which is often recognised too late for long-term intervention.
Source: www.thelancet.comCategories: General Medicine NewsTweet-
I believe we finally have a breakthrough & our patron HRH Haifa Alfaisal bin Abdulaziz Al Saud has certainly been a source of inspiration for this group #TimeToAct #CVDisease is the #1 killer @crfheart @TCT_ME_ @TCTConference @TheLancet 🔗 https://t.co/71UzCcMAri https://t.co/eZYZhc7cDB
-
-
Mashup Score: 5Home | TCT Middle East 2025 - 8 day(s) ago
Powered by the Cardiovascular Research Foundation ® and HeartLinks ®, organized by Konoz Retaj ®, and endorsed by the National Heart Center, this landmark conference will showcase clinical excellence, cutting-edge training, and impactful research across the Middle East and beyond. Take advantage of early-bird pricing though 28 January 2025. Price increases on 29 January! TCT ® Plus Middle East 2025 is accredited for continuing medical education by KonozRetaj (KR). Embark on an extraordinary journey at
Categories: General Medicine NewsTweet-
RT @al_almay: 📢 The Mega Middle East Meeting is here! Open to all—don’t miss out! https://t.co/6WMWhQiF1u
-
-
Mashup Score: 5Home | TCT Middle East 2025 - 9 day(s) ago
Powered by the Cardiovascular Research Foundation ® and HeartLinks ®, organized by Konoz Retaj ®, and endorsed by the National Heart Center, this landmark conference will showcase clinical excellence, cutting-edge training, and impactful research across the Middle East and beyond. Take advantage of early-bird pricing though 28 January 2025. Price increases on 29 January! TCT ® Plus Middle East 2025 is accredited for continuing medical education by KonozRetaj (KR). Embark on an extraordinary journey at
Categories: General Medicine NewsTweet-
RT @al_almay: 📢 The Mega Middle East Meeting is here! Open to all—don’t miss out! https://t.co/6WMWhQiF1u
-
-
Mashup Score: 11
TCT ® Plus Middle East is a premier event focused on the latest advancements and innovations in cardiovascular medicine, interventional cardiology, and cardiovascular technology. The event gathers world-renowned experts, researchers, and health care professionals from across the Middle East and beyond to explore groundbreaking research, cutting-edge technologies, and best practices in the management of cardiovascular diseases. The Program Directors of TCT ® Plus Middle East invite you to this inaugural
Categories: General Medicine NewsTweet-
RT @TCT_ME_: 𝕊ᵗÃⓨเℕg 𝔠ØｎηⓔＣＴᗴ𝓭 A message from the CEO of @crfheart @jgranadacrf 👉 https://t.co/Ff14QfZxwh https://t.co/SiJPqez6zA
-
-
Mashup Score: 11
TCT ® Plus Middle East is a premier event focused on the latest advancements and innovations in cardiovascular medicine, interventional cardiology, and cardiovascular technology. The event gathers world-renowned experts, researchers, and health care professionals from across the Middle East and beyond to explore groundbreaking research, cutting-edge technologies, and best practices in the management of cardiovascular diseases. The Program Directors of TCT ® Plus Middle East invite you to this inaugural
Categories: General Medicine NewsTweet-
RT @TCT_ME_: 𝕊ᵗÃⓨเℕg 𝔠ØｎηⓔＣＴᗴ𝓭 A message from the CEO of @crfheart @jgranadacrf 👉 https://t.co/Ff14QfZxwh https://t.co/SiJPqez6zA
-
-
Mashup Score: 11
TCT ® Plus Middle East is a premier event focused on the latest advancements and innovations in cardiovascular medicine, interventional cardiology, and cardiovascular technology. The event gathers world-renowned experts, researchers, and health care professionals from across the Middle East and beyond to explore groundbreaking research, cutting-edge technologies, and best practices in the management of cardiovascular diseases. The Program Directors of TCT ® Plus Middle East invite you to this inaugural
Categories: General Medicine NewsTweet-
RT @TCT_ME_: 𝕊ᵗÃⓨเℕg 𝔠ØｎηⓔＣＴᗴ𝓭 A message from the CEO of @crfheart @jgranadacrf 👉 https://t.co/Ff14QfZxwh https://t.co/SiJPqez6zA
-
-
Mashup Score: 5Home | TCT Middle East 2025 - 10 day(s) ago
Powered by the Cardiovascular Research Foundation ® and HeartLinks ®, organized by Konoz Retaj ®, and endorsed by the National Heart Center, this landmark conference will showcase clinical excellence, cutting-edge training, and impactful research across the Middle East and beyond. Take advantage of early-bird pricing though 28 January 2025. Price increases on 29 January! TCT ® Plus Middle East 2025 is accredited for continuing medical education by KonozRetaj (KR). Embark on an extraordinary journey at
Categories: General Medicine NewsTweet-
RT @IndiaCvt: MARK YOUR DATES https://t.co/vwUSGvsreF @drptca @mirvatalasnag @mmamas1973 @AnkurKalraMD @aayshacader @NishithChandra @DrSari…
-
-
Mashup Score: 5The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma - 20 day(s) ago
For decades, the management of coronary artery disease has focused on epicardial obstruction and ischaemia, which is often recognised too late for long-term intervention. This approach limits the potential for effective intervention, which particularly concerning because coronary artery disease remains a leading cause of global morbidity and mortality. Current cardiovascular care emphasises restoration of blood flow rather than prevention of disease progression. Despite significant health-care spending
Source: www.thelancet.comCategories: General Medicine NewsTweet-
🎯 highly relevant @rallamee @CotsCardiology https://t.co/qhQCQMhhl5 https://t.co/q0690HL7PH
-
-
Mashup Score: 7ACC.25: The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma - 24 day(s) ago
Mirvat Alasnag provides her take on the Lancet Commission for atherosclerosis published during the ACC.25 in Chicago.
Source: www.pcronline.comCategories: General Medicine NewsTweet-
@TheLancet Commission on CAD: moving from ischaemia to atheroma @PCRonline @rallamee @DrSarahjZaman @DFCapodanno @NievesGonzalo1 @jasonwasfy @nadia_sutton @nickaram et al https://t.co/VPl37xAIyy
-
@djc795 @TCT_ME_ @TAVRBot @drptca @AlkashkariWail @fjsawaya @yassersadeknhi @RodrigoBagur @EkateriniL @DrAlsubei @atunuguntla1 @NielsRHolm We considered it..ergonomics & radiation exposure were a concern This @MyJSCAI statement notes similar mortality & less bleeding .. But radiation & cost an issue https://t.co/DqMPLPC98o https://t.co/ehJnPfm9aJ